What biomarker tests should I ask my doctor about
Based on the NCCN Guidelines for Patients, here are the key biomarker tests you should discuss with your doctor for Lymphoma:
For Follicular Lymphoma (FL): According to the NCCN Guidelines for FL (2024), essential biomarker testing includes:
- Immunophenotyping tests:
- Immunohistochemistry (IHC) panel testing for markers including:
- CD20, CD3, CD5, CD10, BCL2, BCL6, CD21/CD23
- Flow cytometry testing for:
- Kappa/lambda, CD19, CD20, CD5, CD23, CD10
- Genetic testing:
- BCL2 and BCL6 rearrangements
- Testing for chromosome translocations
- Fluorescence in situ hybridization (FISH) studies
For Diffuse Large B-Cell Lymphoma (DLBCL): According to the NCCN Guidelines for DLBCL (2025), key biomarker testing includes:
- Essential genetic tests:
- MYC, BCL2, and BCL6 gene rearrangements
- FISH testing for these rearrangements if MYC is positive
- Karyotype testing
- Immunophenotyping:
- IHC panel including CD3, CD20, CD10, BCL2, BCL6, IRF4/MUM1, and MYC
- Flow cytometry markers including CD3, CD5, CD19, CD10, CD20, CD45
The guidelines emphasize that these tests should be interpreted by expert pathologists and are crucial for accurate diagnosis and treatment planning. Always discuss the full panel of appropriate tests with your healthcare team, as individual needs may vary.
Sources:
- NCCN Guidelines for Patients: Follicular Lymphoma, 2024
- NCCN Guidelines for Patients: Diffuse Large B-Cell Lymphomas, 2025
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Grounded in NCCN Guidelines for Patients (Lymphomas) — the same guidelines oncologists use.
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated October 15, 2025. Informational only — not a substitute for your oncology team.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients (Lymphomas) (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with diagnosis for Lymphoma patients
Have your records handy? Add them to a private case for a deeper, personalized read →
Expert Webinars on Lymphoma
More questions about Lymphoma
- What questions should I ask my oncologist
- Should I see a naturopathic doctor during Lymphoma treatment
- What is the myc biomarker? Does this relate to double hit
- What questions should I ask before starting chemotherapy for Lymphoma
- What questions should I ask about a Lymphoma clinical trial
- What biomarker testing is recommended for early stage Lymphoma
- What imaging tests are used to stage Lymphoma
- What blood tests are used to monitor Lymphoma